Cite
CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
MLA
Mohty, Mohamad, et al. “CD8+ T Cell Dose Affects Development of Acute Graft-vs-Host Disease Following Reduced-Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation.” Experimental Hematology, vol. 32, no. 11, Nov. 2004, pp. 1097–102. EBSCOhost, https://doi.org/10.1016/j.exphem.2004.07.020.
APA
Mohty, M., Bagattini, S., Chabannon, C., Faucher, C., Bardou, V.-J., Bilger, K., Vey, N., Gaugler, B., Stoppa, A.-M., Coso, D., Ladaique, P., Olive, D., Viens, P., & Blaise, D. (2004). CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation. Experimental Hematology, 32(11), 1097–1102. https://doi.org/10.1016/j.exphem.2004.07.020
Chicago
Mohty, Mohamad, Sophie Bagattini, Christian Chabannon, Catherine Faucher, Valerie-Jeanne Bardou, Karin Bilger, Norbert Vey, et al. 2004. “CD8+ T Cell Dose Affects Development of Acute Graft-vs-Host Disease Following Reduced-Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation.” Experimental Hematology 32 (11): 1097–1102. doi:10.1016/j.exphem.2004.07.020.